Makker Gotham's Form 4 filing
Rocket Pharmaceuticals, Inc. (RCKT) · filed Oct 2, 2023
- Accession no.
- 0001140361-23-046452
- Filed
- Oct 2, 2023
- Trade date
- Sep 28-29, 2023
- Filing delay
- 4 days
- Rule 10b5-1 plan
- Not checked
This filing lists 2 non-derivative transactions. Open-market sales total $315.7K. It was filed 4 days after the trade.
Reporting owners
A Form 4 can have several reporting owners, such as a person and a fund they control. Trade tables show the first one.
| Owner | Relationship to the company |
|---|---|
| Makker GothamCIK 0001726391 | Director |
Non-derivative securities (Table I)
Acquisitions and disposals of common stock and similar shares, one row per line on the filing.
| Trade date | Security | Transaction | Shares | Price | Value | Shares after | Ownership | Flags |
|---|---|---|---|---|---|---|---|---|
| Sep 28, 2023 | Common Stock | SSaleDisposed | −10,312 | $21.03 | −$216,861.36 | 1,321,174 | Indirect | |
| Sep 29, 2023 | Common Stock | SSaleDisposed | −4,677 | $21.14 | −$98,871.78 | 1,316,497 | Indirect |
Footnotes and remarks
Livermore keeps the footnotes that transaction prices refer to, all footnotes of amendments (Form 4/A) and the filing's remarks. Other footnotes, such as how indirect holdings are held or the details of a trading plan, are only in the original on SEC EDGAR.
No transaction price on this filing refers to a footnote.